jondoeuk's latest activity

Amplifica raised $26 million in a Series B Preferred Stock financing round. Of particular note, one of the investors is Eli Lilly (US)...

Amplifica published five-month results of a 61-person trial of AMP-303, described as a novel polysaccharide...

Amplifica's AMP-303 phase one trial results came out: ''A statistically significant percentage of study subjects showed a greater than...

More here https://www.wired.com/story/a-hair-loss-study-raises-new-questions-about-aging-cells/

Kintor plans to initiate a phase IIb/III clinical trial of pyrilutamide in combination with minoxidil for the treatment of male...

GT20029 1% BIW (twice per week application).

''In an independent ex vivo human Androgenetic Alopecia model — conducted using intact human hair follicles from male patients with Androgenetic Alopecia, challenged with...

Rubedo Life Sciences announced that it would start a clinical trial in 2026 to test its GPX4 modulator to treat hair loss...

Yes.

''The study met its primary safety endpoint and secondary pharmacokinetic endpoint: the drug was well tolerated with no systemic...

Overall skin aging is also driven by sun exposure, genetics, a natural drop in structural proteins over time, lifestyle factors, and more.

Dihydrotestosterone can contribute to skin aging by inhibiting elastin production...

DHT definitely makes your skin older. I've had it in my body as long as I can remember, and every year that passes my skin just seems to...

Topical Minoxidil is just as good. If you are balding from androgen alopecia, and you combine it with Finasteride (Propecia), you...

Unlike oral finasteride or dutasteride, which reduce systemic DHT levels, pyrilutamide is designed to work locally with a different...